Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Capital Reinvestment Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited capital reinvestment ratio. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Capital Reinvestment Ratio of 0.25x as of June 2023, meaning it reinvests 0% of its operating cash flow (€2.10 Billion) in capital expenditures (€524.46 Million). Check GU5 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2024)
Capital reinvestment ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2024. This chart tracks Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Capital Reinvestment Ratio across 12 annual periods. Also explore Guangzhou Baiyunshan Pharmaceutical Hold equity growth rate to track the company's year-over-year net asset growth rate.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Capital Reinvestment Ratio by Year (2013–2024)
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited capital reinvestment ratio by year from 2013 to 2024. For the full cash flow conversion analysis, see cash flow conversion of Guangzhou Baiyunshan Pharmaceutical Hold.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.33x | €3.44 Billion | €1.13 Billion | ▼ -17.4% |
| 2023 | 0.40x | €4.10 Billion | €1.63 Billion | ▲ +100.7% |
| 2022 | 0.20x | €7.00 Billion | €1.38 Billion | ▼ -10.6% |
| 2021 | 0.22x | €5.67 Billion | €1.25 Billion | ▼ -85.2% |
| 2020 | 1.50x | €585.19 Million | €876.50 Million | ▲ +213.5% |
| 2019 | 0.48x | €5.02 Billion | €2.40 Billion | ▲ +420.8% |
| 2018 | 0.09x | €5.22 Billion | €478.62 Million | ▼ -14.5% |
| 2017 | 0.11x | €1.83 Billion | €196.77 Million | ▲ +19.8% |
| 2016 | 0.09x | €2.54 Billion | €228.03 Million | ▼ -66.2% |
| 2015 | 0.27x | €1.94 Billion | €515.34 Million | ▲ +30.1% |
| 2014 | 0.20x | €1.75 Billion | €356.70 Million | ▼ -22.2% |
| 2013 | 0.26x | €1.34 Billion | €350.35 Million | — |